| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |